We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$683M
AUM Growth
-$27.6M
Cap. Flow
-$58M
Cap. Flow %
-8.49%
Top 10 Hldgs %
12.48%
Holding
2,480
New
648
Increased
511
Reduced
547
Closed
615

Sector Composition

Rank Sector Weight
1 Healthcare 11.26%
2 Technology 10.75%
3 Consumer Discretionary 10.46%
4 Industrials 7.98%
5 Energy 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAN icon
1726
Dana Inc
DAN
$3.06B
$20K ﹤0.01%
900
-2,400
-73% -$48.5K
EPM icon
1727
Evolution Petroleum
EPM
$131M
$20K ﹤0.01%
2,700
HOV icon
1728
Hovnanian Enterprises
HOV
$807M
$20K ﹤0.01%
+194
New +$19K
TAP icon
1729
Molson Coors Class B
TAP
$8.09B
$20K ﹤0.01%
270
-1,139
-81% -$84.5K
AD
1730
Array Digital Infrastructure
AD
$3.05B
$20K ﹤0.01%
500
-900
-64% -$33K
SC
1731
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$20K ﹤0.01%
1,000
EDGW
1732
DELISTED
Edgewater Technology Inc
EDGW
$20K ﹤0.01%
2,700
+1,200
+80% +$8.67K
PMFG
1733
DELISTED
PMFG INC COM STK (DE)
PMFG
$20K ﹤0.01%
+3,763
New +$21.5K
NTP
1734
DELISTED
Nam Tai Property Inc.
NTP
$20K ﹤0.01%
4,262
IPAR icon
1735
Interparfums
IPAR
$3.94B
$19K ﹤0.01%
700
-500
-42% -$13.6K
ZUMZ icon
1736
Zumiez
ZUMZ
$339M
$19K ﹤0.01%
+500
New +$17.1K
CNCE
1737
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$19K ﹤0.01%
1,400
-1,700
-55% -$22K
EPZM
1738
CALL
DELISTED
Epizyme, Inc
EPZM
$19K ﹤0.01%
+1,000
New +$23.4K
HMHC
1739
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$19K ﹤0.01%
+900
New +$18K
TECD
1740
DELISTED
Tech Data Corp
TECD
$19K ﹤0.01%
+300
New +$18K
ADMA icon
1741
ADMA Biologics
ADMA
$2.22B
$18K ﹤0.01%
+1,600
New +$18.3K
ALK icon
1742
Alaska Air
ALK
$5.58B
$18K ﹤0.01%
300
-2,600
-90% -$137K
BDL icon
1743
Flanigan's Enterprises
BDL
$85.7M
$18K ﹤0.01%
+600
New +$14.9K
HCA icon
1744
HCA Healthcare
HCA
$89.5B
$18K ﹤0.01%
250
-940
-79% -$66.1K
TPST icon
1745
Tempest Therapeutics
TPST
$14.6M
0
HALL
1746
DELISTED
Hallmark Financial Services, Inc.
HALL
$18K ﹤0.01%
+150
New +$16.9K
GLOG
1747
CALL
DELISTED
GASLOG LTD
GLOG
$18K ﹤0.01%
900
-100
-10% -$1.96K
VSLR
1748
DELISTED
VIVINT SOLAR, INC.
VSLR
$18K ﹤0.01%
+1,940
New +$22.1K
NCIT
1749
DELISTED
NCI, Inc.
NCIT
$18K ﹤0.01%
+1,800
New +$19K
CNP icon
1750
CenterPoint Energy
CNP
$26.8B
$17K ﹤0.01%
+720
New +$17.2K

Similar funds

Prelude Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Prelude Capital Management held 2,480 positions worth $683M, down 3.9% from $710M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $58M in Q4 2014, closing 615 positions and reducing 547 holdings. Its most notable exit was CONCUR TECHNOLOGIES INC, an estimated $6.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 7.7% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in COVANCE INC. worth $6.1M.

  • Prelude Capital Management's largest Q4 2014 buy was COVANCE INC.: 58,717 shares worth $6.1M.
  • Prelude Capital Management added most to CAREFUSION CORPORATION in Q4 2014, an estimated $9.83M increase.
  • Prelude Capital Management's biggest Q4 2014 reduction was SunCoke Energy, cutting an estimated $4.5M.
  • Prelude Capital Management fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $6.4M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $683M portfolio in Q4 2014.
  • Prelude Capital Management opened 648 new positions and closed 615 in Q4 2014.
  • Prelude Capital Management's portfolio value fell 3.9% quarter-over-quarter to $683M.

Based on Prelude Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.